• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状腺癌的病理特征与预后的关系]

[The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].

作者信息

Liu F S

机构信息

Cancer Institute, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1993 Sep;15(5):381-4.

PMID:8174487
Abstract

Two hundred and thirty-three cases of thyroid carcinoma have been analysed by pathology. All cases were followed up more than 5 years after operation. A systematic investigation on the size of tumors, histological types, tumor cell differentiation, tumor cell infiltration, metastasis in lymph nodes and the interstitial reaction was carried out. The results showed that the survival rate of patients was closely related to the size of tumor. In regard to the histological types, the papillary carcinoma was more favourable in prognosis, and the 5, 10 and 15 year survival rates were much better than those of follicular carcinoma. In the medullary carcinoma and anaplastic carcinoma, there was no patient surviving over 10 years. According to the cell differentiation, the papillary and follicular carcinomas were divided into three grades: grade I (well differentiation), grade II (moderate differentiation) and grade III (poor differentiation). In the papillary carcinoma, the survival of the patients seems to be related to the cell differentiation but without statistical significance. However, in follicular carcinoma of the thyroid, the 5, 10 and 15 year survival rates were closely related to the differentiation of cancer cells. Other factors did not show significance in the prognosis, probably because of a too small number of cases in this group.

摘要

对233例甲状腺癌进行了病理分析。所有病例均在术后随访5年以上。对肿瘤大小、组织学类型、肿瘤细胞分化、肿瘤细胞浸润、淋巴结转移及间质反应进行了系统研究。结果显示,患者的生存率与肿瘤大小密切相关。就组织学类型而言,乳头状癌预后较好,5年、10年和15年生存率均明显优于滤泡状癌。在髓样癌和未分化癌中,无患者存活超过10年。根据细胞分化程度,将乳头状癌和滤泡状癌分为三级:I级(高分化)、II级(中分化)和III级(低分化)。在乳头状癌中,患者的生存率似乎与细胞分化有关,但无统计学意义。然而,在甲状腺滤泡状癌中,5年、10年和15年生存率与癌细胞分化密切相关。其他因素在预后中未显示出显著性,可能是因为该组病例数过少。

相似文献

1
[The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].[甲状腺癌的病理特征与预后的关系]
Zhonghua Zhong Liu Za Zhi. 1993 Sep;15(5):381-4.
2
[Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].[分化型甲状腺癌和C细胞癌淋巴结转移对预后的意义——一项荟萃分析]
Zentralbl Chir. 1997;122(4):259-65.
3
[Lymphadenectomy in thyroid gland carcinoma--staging and therapy].[甲状腺癌的淋巴结清扫术——分期与治疗]
Zentralbl Chir. 1996;121(6):455-8.
4
A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.基于人群的分化型和髓样甲状腺癌生存因素分析。
Otolaryngol Head Neck Surg. 2003 Jan;128(1):115-23. doi: 10.1067/mhn.2003.2.
5
Prognostic factors of insular versus papillary/follicular thyroid carcinoma.甲状腺岛叶癌与乳头状/滤泡状癌的预后因素
Am Surg. 2004 May;70(5):461-6.
6
Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.甲状腺乳头状癌和滤泡状癌中组织学血管侵犯的临床病理意义
J Am Coll Surg. 2004 Mar;198(3):341-8. doi: 10.1016/j.jamcollsurg.2003.11.012.
7
[Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].[分化型甲状腺癌的治疗理念——257例患者25年的治疗结果]
Praxis (Bern 1994). 2000 Nov 2;89(44):1779-97.
8
High recurrent rate of multicentric papillary thyroid carcinoma.多中心性乳头状甲状腺癌的高复发率。
Ann Surg Oncol. 2009 Sep;16(9):2609-16. doi: 10.1245/s10434-009-0565-7. Epub 2009 Jun 16.
9
Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.分化型甲状腺癌生存与复发的多因素分析。AGES、MACIS及风险组评分在墨西哥人群中有用性的比较评估。
J Exp Clin Cancer Res. 2002 Mar;21(1):79-86.
10
[Radical interventions in the treatment of thyroid carcinoma].[甲状腺癌治疗中的根治性干预措施]
Chir Ital. 1994;46(4):66-9.